Medical imaging company XLV Diagnostics nets $3 mln in Series A round
Medical imaging company XLV Diagnostics Inc, a portfolio company of commercialization agent MaRS Innovation, has secured $3 million in a Series A financing round. The funds were provided by U.S.-based foundation Bernard M. Gordon Charitable Remainder Unitrust, and will be used to support continued product development and regulatory approval. Based in Thunder Bay, Ontario, XLV specializes in low-cost, next-generation digital mammography machines. Established in 2011, it was previously funded by MaRS Innovation, the Ontario Institute for Cancer Research, Sunnybrook Health Sciences Centre, Thunder Bay Regional Research Institute and FedNor.
28 May 2014•3 mins read
